Should warfarin be temporarily stopped, continued, or reversed after an acute cardioembolic stroke in patients with atrial fibrillation?
This review highlights the clinical uncertainty and need for further research regarding the optimal management of warfarin following an acute cardioembolic stroke in patients with atrial fibrillation.
Despite anticoagulation for atrial fibrillation, some patients still suffer an ischaemic stroke. The issue of whether to stop or continue warfarin, or possibly to reverse the anticoagulation is an area of uncertainty. Continued anticoagulation may, however, increase haemorrhagic transformation of the infarct. In this article we review the published evidence in an attempt to quantify the risks and benefits of each treatment strategy and identify areas for further research.
Mudd et al. (2010) studied this question.